Amikacin Injection 500mg/2ml
-
Product is not available
Country Of Origin : India
Amikacin Injection
Amikacin Injection is a biocompatible parenteral aminoglycoside antibiotic formulated for systemic bacterial infections, delivering precise 500mg/2ml dosage per injection.
The 2ml standardized volume ensures accurate dosing, supporting reproducible clinical outcomes in professional medical environments.
Key Features:
- Optimized aqueous injectable for rapid systemic absorption
- 500mg active concentration per 2ml unit
- Maintains chemical and physical stability under standard storage
- Minimal injection site discomfort with optimized osmolarity
Attributes:
- 500mg/2ml for predictable therapeutic efficacy
- Injectable formulation with controlled viscosity
- Regulatory-compliant for institutional and hospital use
Composition and Formulation Details
Amikacin Injection contains pharmaceutically pure Amikacin sulfate dissolved in isotonic sterile aqueous media. Stabilizers maintain solubility and prevent degradation. The formulation ensures homogeneity and reproducibility, supporting precise parenteral administration.
Functional Characteristics and Performance
The low-viscosity suspension allows smooth intravenous or intramuscular administration. Predictable pharmacokinetics and consistent bioavailability ensure therapeutic reliability. Stability under ambient and refrigerated conditions supports bulk procurement and institutional usage.
Application and Industry Relevance
Amikacin Injection is suitable for bulk sourcing, OEM supply, and export in hospitals, clinics, and institutional procurement channels. Its regulated pharmaceutical status ensures professional-grade reliability, aligning with clinical protocols for systemic antibiotic therapy.
